Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06510335 · ClinicalTrials.gov registry record · NA
Lavender Essential Oil-based Product System for Sleep
A NA study, sponsored by dōTERRA International.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT06510335: Completed NA study, sponsored by dōTERRA International.
NCT06510335 is a NA study that has completed, run by dōTERRA International. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06510335, a NA study, has completed, sponsored by dōTERRA International.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn whether lavender essential oil-based product system can affect gene expression, serum protein markers, and sleep quality in healthy volunteers. The main questions this study aims to answer are: * Does the lavender essential oil-based product system affect gene expression and protein markers as measured in blood? * Does the lavender essential oil-based product system affect subjective quality of life and sleep assessments? * Is daily use of the product system safe, as measured by laboratory tests and adverse events? The lavender essential oil-based product system contains three components: an essential oil blend, a topical stick, and a dietary supplement. Participants will: * Receive a fitness tracker to monitor their sleep and physical activity. * Use the lavender essential oil-based product system for six weeks total according to this schedule: * 1 week: Essential oil blend * 1 week: Essential oil blend + topical stick * 4 weeks: Essential oil blend + topical stick + dietary supplement * Attend two study visits in which they provide blood and urine samples, and complete subjective sleep and quality of life assessments * Complete weekly subjective sleep assessments from home
Interventions
- OTHER Lavender essential oil-based product system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2023-08-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06510335
The ClinicalTrials.gov registry entry for NCT06510335 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is dōTERRA International, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lavender essential oil-based product system is the first listed.
NCT06510335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06510335 about?
NCT06510335 is a clinical study titled "Lavender Essential Oil-based Product System for Sleep". The goal of this clinical trial is to learn whether lavender essential oil-based product system can affect gene expression, serum protein markers, and sleep quality in healthy volunteers. The main questions this study aims to answer are: * Does the lavender essential oil-based product system affect...
What is the current status of trial NCT06510335?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2023-06-01. Estimated completion is 2023-08-11.
What interventions are being tested in trial NCT06510335?
The interventions under investigation include: Lavender essential oil-based product system (OTHER).
Who is sponsoring clinical trial NCT06510335?
This trial is sponsored by dōTERRA International, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.